BACKGROUND: Total hip arthroplasty (THA) is a beneficial and cost-effective procedure for patients with osteoarthritis. Recent initiatives to improve hospital quality of care include assessing unplanned hospital readmission rates. Patients presenting for THA have different indications and medical comorbidities that may impact rates of readmission. QUESTIONS/PURPOSES: This study measured (1) the unplanned hospital readmission rate in primary THA, revision THA, and antibiotic-spacer staged revision THA to treat infection. Additionally, we determined (2) the medical and surgical causes of readmission; and (3) the risk factors associated with unplanned readmission. METHODS: A total of 1415 patients (988 primary THA, 344 revision THA, 82 antibiotic-spacer staged revision THA to treat infection) from a single institution were included. All hospital readmissions within 90 days of discharge were reviewed. Patient demographics and medical comorbidities were included in a Cox proportional hazards model to assess risk of readmission. RESULTS: The overall unplanned readmission rate was 4% at 30 days and 7% at 90 days. At 90 days, primary THA (5%) had a lower unplanned readmission rate than revision THA (10%, p < 0.001) and antibiotic-spacer staged revision THA (18%, p < 0.001). Medical diagnoses were responsible for almost one-fourth of unplanned readmissions, whereas over half of surgical readmissions were the result of dislocation, surgical site infection, and postoperative hematoma. Type of procedure, hospital stay greater than 5 days, cardiac valvular disease, diabetes with end-organ complications, and substance abuse were each associated with increased risk of unplanned readmission. CONCLUSIONS: Higher rates of unplanned hospital readmissions in revision THA rather than primary THA suggest that healthcare quality measures that incorporate readmission rates as a proxy for quality of care should distinguish between primary and revision procedures. Failure to do so may negatively impact tertiary referral hospitals that often care for patients requiring complex revision procedures.
BACKGROUND:Total hip arthroplasty (THA) is a beneficial and cost-effective procedure for patients with osteoarthritis. Recent initiatives to improve hospital quality of care include assessing unplanned hospital readmission rates. Patients presenting for THA have different indications and medical comorbidities that may impact rates of readmission. QUESTIONS/PURPOSES: This study measured (1) the unplanned hospital readmission rate in primary THA, revision THA, and antibiotic-spacer staged revision THA to treat infection. Additionally, we determined (2) the medical and surgical causes of readmission; and (3) the risk factors associated with unplanned readmission. METHODS: A total of 1415 patients (988 primary THA, 344 revision THA, 82 antibiotic-spacer staged revision THA to treat infection) from a single institution were included. All hospital readmissions within 90 days of discharge were reviewed. Patient demographics and medical comorbidities were included in a Cox proportional hazards model to assess risk of readmission. RESULTS: The overall unplanned readmission rate was 4% at 30 days and 7% at 90 days. At 90 days, primary THA (5%) had a lower unplanned readmission rate than revision THA (10%, p < 0.001) and antibiotic-spacer staged revision THA (18%, p < 0.001). Medical diagnoses were responsible for almost one-fourth of unplanned readmissions, whereas over half of surgical readmissions were the result of dislocation, surgical site infection, and postoperative hematoma. Type of procedure, hospital stay greater than 5 days, cardiac valvular disease, diabetes with end-organ complications, and substance abuse were each associated with increased risk of unplanned readmission. CONCLUSIONS: Higher rates of unplanned hospital readmissions in revision THA rather than primary THA suggest that healthcare quality measures that incorporate readmission rates as a proxy for quality of care should distinguish between primary and revision procedures. Failure to do so may negatively impact tertiary referral hospitals that often care for patients requiring complex revision procedures.
Authors: Javad Parvizi; Alan Mui; James J Purtill; Peter F Sharkey; William J Hozack; Richard H Rothman Journal: J Bone Joint Surg Am Date: 2007-01 Impact factor: 5.284
Authors: Steven Kurtz; Fionna Mowat; Kevin Ong; Nathan Chan; Edmund Lau; Michael Halpern Journal: J Bone Joint Surg Am Date: 2005-07 Impact factor: 5.284
Authors: Carlos B Mantilla; Terese T Horlocker; Darrell R Schroeder; Daniel J Berry; David L Brown Journal: Anesthesiology Date: 2002-05 Impact factor: 7.892
Authors: José M Quintana; Inmaculada Arostegui; Antonio Escobar; Jesus Azkarate; J Ignacio Goenaga; Iratxe Lafuente Journal: Arch Intern Med Date: 2008-07-28
Authors: William W Schairer; Alexandra Carrer; Vedat Deviren; Serena S Hu; Steven Takemoto; Praveen Mummaneni; Dean Chou; Christopher Ames; Shane Burch; Bobby Tay; Aenor Sawyer; Sigurd H Berven Journal: Spine (Phila Pa 1976) Date: 2013-09-01 Impact factor: 3.468
Authors: Elizabeth W Paxton; Maria C S Inacio; Jasvinder A Singh; Rebecca Love; Stefano A Bini; Robert S Namba Journal: Clin Orthop Relat Res Date: 2015-11 Impact factor: 4.176
Authors: Douglas S Weinberg; Matthew J Kraay; Steven J Fitzgerald; Vasu Sidagam; Glenn D Wera Journal: Clin Orthop Relat Res Date: 2016-11-11 Impact factor: 4.176
Authors: Daniel R Evans; Alexander L Lazarides; Mark M Cullen; Julia D Visgauss; Jason A Somarelli; Dan G Blazer; Brian E Brigman; William C Eward Journal: Ann Surg Oncol Date: 2021-05-20 Impact factor: 5.344
Authors: Robert S White; Dahniel L Sastow; Licia K Gaber-Baylis; Virginia Tangel; Andrew D Fisher; Zachary A Turnbull Journal: J Racial Ethn Health Disparities Date: 2018-02-12
Authors: Pablo A Slullitel; Martín Estefan; Wilber M Ramírez-Serrudo; Fernando M Comba; Gerardo Zanotti; Francisco Piccaluga; Martín A Buttaro Journal: Int Orthop Date: 2018-03-10 Impact factor: 3.075